SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein
Por um escritor misterioso
Descrição
Abstract Pilomatricomas are benign tumors originating from the capillary matrix, which may
Real‐World Evidence for the NINLARO® (ixazomib) Regimen
Demonstrated Clinical Efficacy with NINLARO® (ixazomib)
Lenalidomide-based triplet regimens in first relapsed multiple myeloma patients: real-world evidence from a propensity score matched analysis
Current ConCepts in Dermatology
Recurrent MET fusion genes represent a drug target in pediatric glioblastoma
Frontiers Variation in TAS2R receptor genes explains differential bitterness of two common antibiotics
SciELO - Brasil - New proteasome inhibitors in the treatment of multiple myeloma New proteasome inhibitors in the treatment of multiple myeloma
Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial - The Lancet Oncology
Population pharmacokinetics and exposure–response of selumetinib and its N‐desmethyl metabolite in pediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas
Combining carfilzomib and panobinostat to treat relapsed/refractory multiple myeloma: results of a Multiple Myeloma Research Consortium Phase I Study
SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein-Taybi syndrome, Multiple pilomatricomas in twins with Rubinstein-Taybi syndrome,
Frontiers SDHB exon 1 deletion: A recurrent germline mutation in Colombian patients with pheochromocytomas and paragangliomas
SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein-Taybi syndrome, Multiple pilomatricomas in twins with Rubinstein-Taybi syndrome,
Multiple pilomatricomas by the numbers
de
por adulto (o preço varia de acordo com o tamanho do grupo)
